Part:BBa_K5036029
dCas9(C)_NLS-Syn-VEGFR-1 (VEGF-R1, C-TEV, NLS, TCS(Q,L), HA,dCas9(C),VP64,GFP)
Part Description
In our first receptor chain, we've engineered a system that responds to tissue injury. An external domain, VEGF-R1, is attached to an internal domain composed of C terminal domain of TEV protease, a nuclear localization signal (NLS), a TEV cleavage site(TCS(Q,L)), and dCas9(C) which is linked to transcription activator VP64
Usage
this is our receptor's first chain. our receptor is activated after binding of VEGF to the external domain which is designed to attach specifically to it. after activation the two domains of TEV dimerizes forming catalytically active TEV protease which will cleave the two chains at TCS. upon cleavage of the two chains the two domains of dCas9 dimerize and is released attached to transcription activator to be guided to its direction
This figure illustrates variant of our receptor's first chain where TCS (Q, L) is to it.
Dry lab Characterization
we had the chance to match the external domains with different internal domain components to select single suitable receptor chain. The whole chain affinity is affected by the internal domain, thus we had to try VEGFR1Cdcas with VEGFA:
VEGFR1Cdcas-VEGFA
The interaction between the chain composed of VEGFR1 as an external domain and Cdcas9 as an internal domain with VEGFA yields ΔG of -11.2 kcal mol-1 .
Then we have made a comparison between the four receptor chain variants’ binding stability with VEGFA.
This figure shows that VEGFR2Cdcas-VEGFA complex has the highest stability among other variants and VEGFR1NdCas9-VEGFA complex has the lowest stability among other variants .
The final form of our receptor is composed of two chains, each chain is built of internal and external domains, so we validated these interactions by calculating the binding affinity between the two chains and VEGFA, which simulate the final design of our receptor.
(VEGFR1-Cdcas9 – VEGFR1-Ndcas9) with VEGFA
The figure displays the interaction between two receptor chains and VEGFA, The (VEGFR1-Cdcas9) chain appears in the red colour, and the (VEGFR1-Ndcas9) chain appears in the blue colour. The VEGFA is in green colour. The calculated binding stability (ΔG) of the combination is -12.9 kcal mol-1 .
The final form of our receptor is composed of two chains, each chain is built of internal and external domains, so we validated these interactions by calculating the binding affinity between the two chains and VEGFA, which simulate the final design of our receptor.
(VEGFR1-Cdcas9 – VEGFR2-Ndcas9) with VEGFA
The figure displays the interaction between two receptor chains and VEGFA, The (VEGFR1-Cdcas9) chain appears in the red colour, and the (VEGFR2-Ndcas9) chain appears in the blue colour. The VEGFA is in green colour. The calculated binding stability (ΔG) of the combination is -13.7 kcal mol-1 .
The receptor chains’ affinity could be affected by the internal domains interactions with the external domains, so we compared between the receptors’ variants to choose the best receptor design in our project.
The figure shows that the combination of VEGFR1-Cdcas9 and VEGFR2-Ndcas9 took the upper hand among other variants .
Characterization by Mathematical Modeling
The model provides the interaction kinetics of VEGFR1 receptor upon binding of VEGF to it , the result shows satisfactory binding affinity and stability based on parametric values from literature
Graph (1). Illustrates the decreasing of free VEGFR (Black line) upon binding of VEGF to one of the receptor chains to form (RA) complex (Yellow line), that bind directly to the other chain of the receptor to final form the fitted ligand receptor complex (RAR) to reach 0.2 .
The continuation of the first model provides the activation kinetics of the TEV protease which occurs subsequent to the binding of VEGF to our receptor allowing the dimerization process for the receptor chains to take place. The result shows TEV protease activation based on parametric values from literature
Graph (2). Illustrates the dimerization level (Blue line) that reaches (7.8) upon binding of VEGF to its receptor to activate TEV protease (Red line), The activation level reaches (6.5) to release d-Cas9 system .
The continuation of the second model provides the activation kinetics of the d-Cas9 system which occurs subsequent to cleavage activity of TEV protease after its activation. The result shows increase in d-Cas9 activity which implies successful cleavage of the TEV protease for releasing the N and C terminal of the d-Cas9 system and its assembly based on parametric values from literature
Graph (2). Illustrates the released d-Cas9 system that activation reaches (110), upon activation of TEV protease .
Experimental Characterization
N-TEV and C-TEV segments Was connected to NES-dCas9(N) and NLS-dCas9(C)VP64, respectively, using a flexible link . To find the best dCas9-synVEGFR structure, TEV(N)-NES-dCas9(N) and TEV(C)-NLS-dCas9(C)VP64 was joined to the VEGFR1(FLT1) and VEGFR2(KDR) ectodomains . These combinations were tested in HEK293T cells and the activity of each homo- and hetero-dimer was measured with and without transgenically expressed VEGFA121
The graph demonstrates that the EYFP reporter, a marker of activation score, was significantly upregulated when a C-terminal dCas9 was fused to VEGFR-1 and an N-terminal dCas9 was fused to VEGFR-2 were employed in combination. This effect was particularly pronounced in the presence of VEGFA121 outperforming other dCas9-VEGFR constructs. In addition to this, the combination of VEGFR2: TEV(N)-NES-dCas9(N)/VEGFR1: TEV(C)-NLS-dCas9(C)VP64 heterodimer shows very low activation score in absence of VEGFA121 .
It was hypothesized that by fine-tuning the TCS modules, the assembly of dCas9-VP64 could be controlled so that it only occurs upon simultaneous activation of VEGFR1 and VEGFR2. To investigate this, a set of dCas9(N)-synVEGFR2 and dCas9(C)-synVEGFR1 variants with TCS sequences that had been engineered to weaken their interaction with TEV were designed.Then These combinations were tested in HEK293T cells and the activity of different dCas9-VEGFR variants with TCS sequences was measured with and without transgenically expressed VEGFA121
Among the tested dCas9-VEGFR constructs, a combination of dCas9-VEGFR2 with a low-affinity TCS(QL) and dCas9-VEGFR1 with a high-affinity TCS(QG) exhibited relatively low basal activity in absence of VEGFA 121 while preserving high activation score in comparison to other constructs in presence of VEGFA 121. In other words, the previous combination shows the most specific activation of the EYFP reporter in response to VEGFA 121 .
A HEK293 cell line was engineered to express the VEGFR2: TEV(N)-NES-dCas9(N)/VEGFR1: TEV(C)-NLS-dCas9(C)VP64 heterodimer. To assess the effectiveness of the system, flow cytometry was used to compare EYFP reporter expression in cells transfected with either a control sgRNA or one targeting EYFP.
Flow cytometry analysis of cells expressing dCas9-VEGFR constructs with either a control sgRNA (sgSCR) or a targeting sgRNA (sgEYFP) revealed that the receptor configuration treated with the targeting sgRNA was unresponsive to activation without VEGFA121 but exhibited a strong response to VEGFA121, with up to a 1,000-fold increase in EYFP activation .
dCas9-VP64-GAL4 expression vector and a UAS-CMV trans-enhancer were constructed to investigate the effectiveness of the GAL4-UAS system for CRISPR-assisted trans-enhancer activation . Both linear (LUAS-CMV) and circular (CUAS-CMV) forms of the UAS-CMV enhancer were successfully recruited to target genes by the dCas9-VP64-fused GAL4 protein.When co-transfected with a reporter gene in 293T cells, both LUAS-CMV and CUAS-CMV significantly activated gene expression on opposite of control conditions.
This figure show Flow cytometry analysis of ZsGreen expression shows very high gene expression with (dCas9-VP64-GAL4/sgRNA-LUAS-CMV) and (dCas9-VP64-GAL4/sgRNA- CUAS-CMV) .
This figure shows graphic illustration of flow cytometry analysis of 293 T cells which shows high gene expression with both LUAS-CMV and CUAS-CMV. These findings highlight the potential of the GAL4-UAS system for efficient CRISPR-mediated trans-enhancer activation .
Also these vectors ( dCas9-VP64-GAL4 with linear (LUAS-CMV) and circular (CUAS-CMV) CMV enhancer) were constructed and co-transfected with a reporter gene(HNF4α gene) in HepG2 cells . then results were illustrated and compared with the results of the same construcrts in 293T cells.
This figure shows graphic illustration of flow cytometry analysis of 293 T cells and HepG2 cells which shows high gene expression with (dCas9-VP64-GAL4/sgRNA-LUAS-CMV) and (dCas9-VP64-GAL4/sgRNA- CUAS-CMV). Gene expression was higher in HepG2 cells. These findings highlight the potential of the GAL4-UAS system for efficient CRISPR-mediated trans-enhancer activation .
Reference
Mac Gabhann F, Popel AS. Dimerization of VEGF receptors and implications for signal transduction: a computational study. Biophys Chem. 2007 Jul;128(2-3):125-39. doi: 10.1016/j.bpc.2007.03.010. Epub 2007 Mar 24. PMID: 17442480; PMCID: PMC2711879.
Sequence and Features
- 10COMPATIBLE WITH RFC[10]
- 12INCOMPATIBLE WITH RFC[12]Illegal NheI site found at 2173
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25INCOMPATIBLE WITH RFC[25]Illegal NgoMIV site found at 3973
Illegal NgoMIV site found at 4046
Illegal NgoMIV site found at 4531
Illegal NgoMIV site found at 5440 - 1000INCOMPATIBLE WITH RFC[1000]Illegal BsaI.rc site found at 6737
Illegal SapI.rc site found at 3268
| None |